Q-RNA
Business Services · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
3960 Broadway Ste 407, New York, New Yor...Phone Number
(212) 568-0365Website
www.q-rna.comRevenue
<$5 MillionIndustry
About Q-RNA
Is Q-RNA your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Q-RNA has new funding data
Product Launch: Get notified when Q-RNA launches new products
Check out if Q-RNA is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Q-RNA
Website visits: Recent activity has been detected on your website
Click to see if Q-RNA had a recent Job posting/layoffs
Q-RNA, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Q-RNA recently announced quarterly report
Check if Q-RNA has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Q-RNA as Masked Content
Find more new buyers
Compare Similar Companies to Q-RNA
Compare insights from companies similar to Q-RNA, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Q-RNA
Company Profile Activity
Activity Insights
Q-RNA is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Q-RNA is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Q-RNA.
Q-RNA Tech Stack
A closer look at the technologies used by Q-RNA
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Q-RNA
It is Q-RNA's mission to develop its novel drug target and discovery systems and use them to discover and optimize therapeutics to treat Alzheimer's disease (AD), a disorder with a large unmet medical need. With its initial focus on Alzheimer's disease, the Company will begin with a library of anti-amyloid compounds designed by a former founder of... Read More